CWM
IBB icon

Concert Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Concert Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,591
Closed -$320K – 277
2017
Q1 		$320K Sell
3,591
-18
-0.5% -$1.72K 0.07% 340
2016
Q4 		$322K Buy
3,609
+51
+1% +$4.64K 0.07% 341
2016
Q3 		$344K Sell
3,558
-486
-12% -$46.2K 0.04% 452
2016
Q2 		$352K Sell
4,044
-303
-7% -$27.2K 0.05% 418
2016
Q1 		$379K Buy
4,347
+1,446
+50% +$129K 0.05% 409
2015
Q4 		$327K Sell
2,901
-522
-15% -$56.7K 0.04% 454
2015
Q3 		$345K Sell
3,423
-5,145
-60% -$617K 0.05% 442
2015
Q2 		$1.05M Buy
8,568
+2,028
+31% +$243K 0.14% 192
2015
Q1 		$493K Buy
6,540
+411
+7% +$45.3K 0.14% 205
2014
Q4 		$616K Buy
6,129
+2,100
+52% +$204K 0.09% 275
2014
Q3 		$365K Sell
4,029
-8,958
-69% -$786K 0.05% 341
2014
Q2 		$1.05M Sell
12,987
-8,202
-39% -$646K 0.13% 128
2014
Q1 		$1.62M Sell
21,189
-2,346
-10% -$195K 0.2% 66
2013
Q4 		$1.78M Buy
23,535
+849
+4% +$60.2K 0.23% 62
2013
Q3 		$1.59M Sell
22,686
-5,217
-19% -$342K 0.23% 61
2013
Q2 		$1.61M Buy
+27,903
New +$1.61M 0.24% 43

Other funds holding IBB

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Concert Wealth Management's IBB Position: Q2 2017 in Review

Concert Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q2 2017, closing a stake of 3,591 shares — an estimated $320K sold.

Concert Wealth Management first reported a position in IBB in Q2 2013 and held it in 16 quarters. The position peaked at $1.78M in Q4 2013. 562 funds tracked by Wall St. Rank hold IBB as of Q2 2017.

  • Concert Wealth Management reported no remaining iShares Biotechnology ETF position as of Q2 2017 after selling out during the quarter.
  • Concert Wealth Management sold 3,591 iShares Biotechnology ETF shares in Q2 2017, an estimated $320K.
  • Concert Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 16 quarters.
  • Concert Wealth Management's iShares Biotechnology ETF position peaked at $1.78M in Q4 2013.
  • 562 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2017.

Based on Concert Wealth Management's 13F filing for Q2 2017, filed 10 Aug 2017.